Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jan Danser
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Anatomy
Living Beings
Disorders
Sign-in to see full Profile
Network (preview)
47
Schalekamp, Maarten
28
Saxena, Pramod
26
Derkx, Frans
17
van Kats, Jorge
16
de Vries, René
16
Garrelds, Ingrid
14
Batenburg, Wendy
13
Schuijt, Martin
11
Verdouw, Pieter
10
deinum, jaap
9
Lamers, Jos
8
Saris, Jasper
8
Tom, Beril
7
Chai, Wenxia
6
van Kesteren, CA
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jan Danser (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Persson Frederik; Rossing Peter; Reinhard Henrik; Juhl Tina; Stehouwer Coen D A; Schalkwijk Casper; Danser A H Jan; Boomsma Frans; Frandsen Erik; Parving Hans-Henrik
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.
Diabetes care 2009;32(10):1873-9.
-
2009: Krop Manne; van Veghel Richard; Garrelds Ingrid M; de Bruin René J A; van Gool Jeanette M G; van den Meiracker Anton H; Thio Marco; van Daele Paul L A; Danser A H Jan
Cardiac Renin levels are not influenced by the amount of resident mast cells.
Hypertension 2009;54(2):315-21.
-
2009: Danser A H Jan
(Pro)renin receptor and vacuolar H+-ATPase.
Hypertension 2009;54(2):219-21.
-
2009: Batenburg Wendy W; Kappers Mariette H W; Eikmann Melissa J; Ramzan Serge N A; de Vries René; Danser A H Jan
Light-induced vs. bradykinin-induced relaxation of coronary arteries: do S-nitrosothiols act as endothelium-derived hyperpolarizing factors?
Journal of hypertension 2009;27(8):1631-40.
-
2009: Campbell Duncan J; Nussberger Juerg; Stowasser Michael; Danser A H Jan; Morganti Alberto; Frandsen Erik; Ménard Joël
Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement.
Clinical chemistry 2009;55(5):867-77.
-
2009: Jansen Pieter M; Danser A H Jan; Imholz Ben P; van den Meiracker Anton H
Aldosterone-receptor antagonism in hypertension.
Journal of hypertension 2009;27(4):680-91.
-
2009: Klotz Stefan; Burkhoff Daniel; Garrelds Ingrid M; Boomsma Frans; Danser A H Jan
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
European heart journal 2009;30(7):805-12.
-
2009: Brugts J J; de Maat M P M; Boersma E; Witteman J C M; van Duijn C; Uitterlinden A G; Bertrand M; Remme W; Fox K; Ferrari R; Danser A H J; Simoons M L;
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2009;23(2):171-81.
-
2009: van den Heuvel Mieke; Batenburg Wendy W; Danser A H Jan
Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis?
Molecular and cellular endocrinology 2009;302(2):213-8.
-
2008: Krebs Christian; Weber Matthias; Steinmetz Oliver; Meyer-Schwesinger Catherine; Stahl Rolf; Danser A H Jan; Garrelds Ingrid; van Goor Harry; Nguyen Genevieve; Müller Dominik; Wenzel Ulrich
Effect of (pro)renin receptor inhibition by a decoy peptide on renal damage in the clipped kidney of Goldblatt rats.
Kidney international 2008;74(6):823-4.
-
2008: Gembardt Florian; Heringer-Walther Silvia; van Esch Joep H M; Sterner-Kock Anja; van Veghel Richard; Le Thu H; Garrelds Ingrid M; Coffman Thomas M; Danser A H Jan; Schultheiss Heinz-Peter; Walther Thomas
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(8):3068-77.
-
2008: Brugts Jasper J; Danser A H Jan; de Maat Moniek P M; den Uil Corstiaan A; Boersma Eric; Ferrari Roberto; Simoons Maarten L
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.
Current opinion in cardiology 2008;23(4):296-301.
-
2008: Batenburg Wendy W; de Bruin René J A; van Gool Jeanette M G; Müller Dominik N; Bader Michael; Nguyen Geneviève; Danser A H Jan
Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(6):1151-7.
-
2008: Danser A H Jan; Batenburg Wendy W; van Esch Joep H M; Krop Manne
Prorenin anno 2008.
Journal of molecular medicine (Berlin, Germany) 2008;86(6):655-8.
-
2008: Nguyen Geneviève; Danser A H Jan
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents.
Experimental physiology 2008;93(5):557-63.
-
2008: Krop Manne; Danser A H Jan
Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin.
Current hypertension reports 2008;10(2):112-8.
-
2008: Danser A H Jan; Charney Alan; Feldman David L; Nussberger Juerg; Fisher Naomi; Hollenberg Norman
The renin rise with aliskiren: it's simply stoichiometry.
Hypertension 2008;51(4):e27-8; author reply e29.
-
2007: Danser A H Jan
Renin academy in focus.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2007;8(4):212.
-
2007: Batenburg Wendy W; Krop Manne; Garrelds Ingrid M; de Vries René; de Bruin René J A; Burcklé Celine A; Müller Dominik N; Bader Michael; Nguyen Geneviève; Danser A H Jan
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor.
Journal of hypertension 2007;25(12):2441-53.
-
2007: Krebs C; Hamming I; Sadaghiani S; Steinmetz O M; Meyer-Schwesinger C; Fehr S; Stahl R A K; Garrelds I M; Danser A H J; van Goor H; Contrepas A; Nguyen G; Wenzel U
Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats.
Kidney international 2007;72(6):725-30.
-
2007: Danser A H Jan
Novel drugs targeting hypertension: renin inhibitors.
Journal of cardiovascular pharmacology 2007;50(2):105-11.
-
2007: Schelleman Hedi; Klungel Olaf H; Witteman Jacqueline C M; Breteler Monique M B; Yazdanpanah Moygan; Danser A H Jan; Hofman Albert; van Duijn Cornelia M; de Boer Anthonius; Stricker Bruno H Ch
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
European journal of human genetics : EJHG 2007;15(4):478-84.
-
2007: Klotz Stefan; Danser A H Jan; Foronjy Robert F; Oz Mehmet C; Wang Jie; Mancini Donna; D'Armiento Jeanine; Burkhoff Daniel
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Journal of the American College of Cardiology 2007;49(11):1166-74.
-
2007: Danser A H Jan; Batenburg Wendy W; van den Meiracker Anton H; Danilov Sergei M
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
Pharmacology & therapeutics 2007;113(3):607-18.
-
2006: Chai Wenxia; Hoedemaekers Yvonne; van Schaik Ron H N; van Fessem Marianne; Garrelds Ingrid M; Saris Jasper J; Dooijes Dennis; ten Cate Folkert J; Kofflard Marcel M J; Danser A H Jan
Cardiac aldosterone in subjects with hypertrophic cardiomyopathy.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7(4):225-30.
-
2006: Chai Wenxia; Danser A H Jan
Why are mineralocorticoid receptor antagonists cardioprotective?
Naunyn-Schmiedeberg's archives of pharmacology 2006;374(3):153-62.
-
2006: Krop Manne; van Esch Joep H M; Danser A H Jan
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
Circulation 2006;114(17):e556; author reply e557.
-
2006: Nguyen Geneviève; Danser A H Jan
The (pro)renin receptor: therapeutic consequences.
Expert opinion on investigational drugs 2006;15(10):1131-5.
-
2006: Batenburg Wendy W; van Esch Joep H M; Garrelds Ingrid M; Jorde Ulrich; Lamers Jos M J; Dekkers Dick H W; Walther Thomas; Kellett Elaine; Milligan Graeme; van Kats Jorge P; Danser A H Jan
Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.
Journal of hypertension 2006;24(7):1355-63.
-
2006: Danser A H Jan
Prorenin: back into the arena.
Hypertension 2006;47(5):824-6.
-
2006: Schalekamp M A D H; Danser A H J
Angiotensin II production and distribution in the kidney: I. A kinetic model.
Kidney international 2006;69(9):1543-52.
-
2006: Schalekamp M A D H; Danser A H J
Angiotensin II production and distribution in the kidney--II. Model-based analysis of experimental data.
Kidney international 2006;69(9):1553-7.
-
2006: Chai Wenxia; Garrelds Ingrid M; de Vries René; Danser A H Jan
Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
Hypertension 2006;47(4):665-70.
-
2005: Danser A H Jan; Deinum Jaap
Renin, prorenin and the putative (pro)renin receptor.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(3):163-5.
-
2005: Danser A H Jan; Deinum Jaap
Renin, prorenin and the putative (pro)renin receptor.
Hypertension 2005;46(5):1069-76.
-
2005: Chai Wenxia; Garrelds Ingrid M; de Vries René; Batenburg Wendy W; van Kats Jorge P; Danser A H Jan
Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.
Hypertension 2005;46(4):701-6.
-
2005: van Kats Jorge P; Chai Wenxia; Duncker Dirk J; Schalekamp Maarten A D H; Danser A H Jan
Adrenal angiotensin: origin and site of generation.
American journal of hypertension 2005;18(8):1104-10.
-
2005: Klotz Stefan; Foronjy Robert F; Dickstein Marc L; Gu Anguo; Garrelds Ingrid M; Danser A H Jan; Oz Mehmet C; D'Armiento Jeanine; Burkhoff Daniel
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Circulation 2005;112(3):364-74.
-
2005: Chai Wenxia; Garrelds Ingrid M; Arulmani Udayasankar; Schoemaker Regien G; Lamers Jos M J; Danser A H Jan
Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
British journal of pharmacology 2005;145(5):664-71.
-
2005: Chai Wenxia; Danser A H Jan
Is angiotensin II made inside or outside of the cell?
Current hypertension reports 2005;7(2):124-7.
-
2005: Batenburg Wendy W; Tom Beril; Schuijt Martin P; Danser A H Jan
Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s).
Vascular pharmacology 2005;42(3):109-18.
-
2005: Danser A H Jan; Saris Jasper J
77th Scientific Sessions of the American Heart Association.
Expert opinion on investigational drugs 2005;14(2):203-7.
-
2005: van Esch Joep H M; Tom Beril; Dive Vincent; Batenburg Wendy W; Georgiadis Dimitris; Yiotakis Athanasios; van Gool Jeanette M G; de Bruijn René J A; de Vries René; Danser A H Jan
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
Hypertension 2005;45(1):120-5.
-
2004: Batenburg Wendy W; de Vries René; Saxena Pramod R; Danser A H Jan
L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries?
Journal of hypertension 2004;22(10):1927-36.
-
2004: Batenburg Wendy W; Garrelds Ingrid M; Bernasconi Catherine Chapuis; Juillerat-Jeanneret Lucienne; van Kats Jorge P; Saxena Pramod R; Danser A H Jan
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Circulation 2004;109(19):2296-301.
-
2004: Batenburg Wendy W; Popp Rüdiger; Fleming Ingrid; de Vries René; Garrelds Ingrid M; Saxena Pramod R; Danser A H Jan
Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?
British journal of pharmacology 2004;142(1):125-35.
-
2004: Danser A H Jan
Endothelin-1 and blood pressure in women.
Journal of hypertension 2004;22(4):675-6.
-
2004: Batenburg Wendy W; Garrelds Ingrid M; van Kats Jorge P; Saxena Pramod R; Danser A H Jan
Mediators of bradykinin-induced vasorelaxation in human coronary microarteries.
Hypertension 2004;43(2):488-92.
-
2003: Schuijt Martin P; Tom Beril; de Vries René; Saxena Pramod R; Sluiter Wim; van Kats Jorge P; Danser A H
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
Journal of hypertension 2003;21(12):2335-44.
-
2003: Tom Beril; Dendorfer Andreas; Danser A H Jan
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
The international journal of biochemistry & cell biology 2003;35(6):792-801.
-
2003: Danser A H Jan
Local renin-angiotensin systems: the unanswered questions.
The international journal of biochemistry & cell biology 2003;35(6):759-68.
-
2003: Tom Beril; Garrelds Ingrid M; Scalbert Elizabeth; Stegmann Alexander P A; Boomsma Frans; Saxena Pramod R; Danser A H Jan
ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):251-6.
-
2002: Schuijt Martin P; Danser A H Jan
Cardiac angiotensin II: an intracrine hormone?
American journal of hypertension 2002;15(12):1109-16.
-
2002: Aartsen Wendy M; Schuijt Martin P; Danser A H Jan; Daemen Mat J A P; Smits Jos F M
The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice.
Cardiovascular research 2002;56(2):205-13.
-
2002: van den Eijnden Mark M E D; de Bruin René J A; de Wit Elly; Sluiter Wim; Deinum Jaap; Reudelhuber Timothy L; Danser A H Jan
Transendothelial transport of renin-angiotensin system components.
Journal of hypertension 2002;20(10):2029-37.
-
2002: Schuijt Martin P; Saxena Pramod R; Danser A H Jan
No net effect of angiotensin II on blood pressure?
Hypertension 2002;39(5):E27-8.
-
2002: Saris Jasper J; van den Eijnden Mark M E D; Lamers Jos M J; Saxena Pramod R; Schalekamp Maarten A D H; Danser A H Jan
Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II.
Hypertension 2002;39(2 Pt 2):573-7.
-
2002: Schuijt Martin P; de Vries René; Saxena Pramod R; Schalekamp Maarten A D H; Danser A H Jan
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
British journal of pharmacology 2002;135(1):275-83.
-
2001: Deinum J; van Gool J M; Kofflard M J; ten Cate F J; Danser A H
Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy.
Hypertension 2001;38(6):1278-81.
-
2001: van Kats J P; Schalekamp M A; Verdouw P D; Duncker D J; Danser A H
Intrarenal angiotensin II: interstitial and cellular levels and site of production.
Kidney international 2001;60(6):2311-7.
-
2001: Gerlofs-Nijland M E; Assmann K J; Dijkman H B; Dieker J W; van Son J P; Mentzel S; van Kats J P; Danser A H; Smithies O; Groenen P J; Wetzels J F
Albuminuria in mice after injection of antibodies against aminopeptidase A: role of angiotensin II.
Journal of the American Society of Nephrology : JASN 2001;12(12):2711-20.
-
2001: Schuijt M P; Basdew M; van Veghel R; de Vries R; Saxena P R; Schoemaker R G; Danser A H
AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction.
American journal of physiology. Heart and circulatory physiology 2001;281(6):H2590-6.
-
2001: Tom B; de Vries R; Saxena P R; Danser A H
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Hypertension 2001;38(1):95-9.
-
2001: Tom B; de Vries R; Saxena P R; Danser A H
Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxide.
Journal of hypertension 2001;19(7):1289-93.
-
2001: van den Eijnden M M; Saris J J; de Bruin R J; de Wit E; Sluiter W; Reudelhuber T L; Schalekamp M A; Derkx F H; Danser A H
Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(6):911-6.
-
2001: de Lannoy L M; Schuijt M P; Saxena P R; Schalekamp M A; Danser A H
Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart.
Journal of hypertension 2001;19(5):959-65.
-
2001: van Kats J P; van Meegen J R; Verdouw P D; Duncker D J; Schalekamp M A; Danser A H
Subcellular localization of angiotensin II in kidney and adrenal.
Journal of hypertension 2001;19(3 Pt 2):583-9.
-
2001: Saris J J; Derkx F H; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.
Hypertension 2001;37(2 Part 2):710-5.
-
2000: Danser A H; Schuijt M P
18th Scientific meeting of the International Society of Hypertension.
Expert opinion on investigational drugs 2000;9(10):2419-23.
-
2000: van Kats J P; Duncker D J; Haitsma D B; Schuijt M P; Niebuur R; Stubenitsky R; Boomsma F; Schalekamp M A; Verdouw P D; Danser A H
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II.
Circulation 2000;102(13):1556-63.
-
2000: Danser A H; Tom B; de Vries R; Saxena P R
L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition.
British journal of pharmacology 2000;131(2):195-202.
-
2000: Saris J J; van Dijk M A; Kroon I; Schalekamp M A; Danser A H
Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Hypertension 2000;35(3):764-8.
-
2000: van Dijk M A; Kroon I; Kamper A M; Boomsma F; Danser A H; Chang P C
The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm.
Journal of cardiovascular pharmacology 2000;35(3):484-90.
-
1999: Schuijt M P; van Kats J P; de Zeeuw S; Duncker D J; Verdouw P D; Schalekamp M A; Danser A H
Cardiac interstitial fluid levels of angiotensin I and II in the pig.
Journal of hypertension 1999;17(12 Pt 2):1885-91.
-
1999: Schuijt M P; de Vries R; Saxena P R; Danser A H
No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats.
Journal of hypertension 1999;17(12 Pt 2):1879-84.
-
1999: Danser A H; Deinum J; Osterop A P; Admiraal P J; Schalekamp M A
Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.
Journal of hypertension 1999;17(12 Pt 2):1867-72.
-
1999: MaassenVanDenBrink A; de Vries R; Saxena P R; Schalekamp M A; Danser A H
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
Cardiovascular research 1999;44(2):407-15.
-
1999: Danser A H; Saris J J; Schuijt M P; van Kats J P
Is there a local renin-angiotensin system in the heart?
Cardiovascular research 1999;44(2):252-65.
-
1999: Danser A H; Schunkert H
Renin-angiotensin system and blood pressure.
Circulation 1999;100(17):e85-6.
-
1999: van Kesteren C A; Saris J J; Dekkers D H; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.
Cardiovascular research 1999;43(1):148-56.
-
1999: Admiraal P J; van Kesteren C A; Danser A H; Derkx F H; Sluiter W; Schalekamp M A
Uptake and proteolytic activation of prorenin by cultured human endothelial cells.
Journal of hypertension 1999;17(5):621-9.
-
1998: Danser A H; Admiraal P J; Derkx F H; Schalekamp M A
Angiotensin I-to-II conversion in the human renal vascular bed.
Journal of hypertension 1998;16(12 Pt 2):2051-6.
-
1998: Danser A H; Derkx F H; Hense H W; Jeunemaître X; Riegger G A; Schunkert H
Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels.
Journal of hypertension 1998;16(12 Pt 2):1879-83.
-
1998: Osterop A P; Kofflard M J; Sandkuijl L A; ten Cate F J; Krams R; Schalekamp M A; Danser A H
AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
Hypertension 1998;32(5):825-30.
-
1998: Schunkert H; Hense H W; Bröckel U; Luchner A; Muscholl M; Holmer S R; Danser A H; Mayer B; Riegger G A
Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample.
Journal of internal medicine 1998;244(2):109-19.
-
1998: Holmer S R; Hense H W; Danser A H; Mayer B; Riegger G A; Schunkert H
Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
Heart (British Cardiac Society) 1998;80(1):45-8.
-
1998: van Kats J P; Danser A H; van Meegen J R; Sassen L M; Verdouw P D; Schalekamp M A
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions.
Circulation 1998;98(1):73-81.
-
1998: Danser A H; Derkx F H; Schalekamp M A; Hense H W; Riegger G A; Schunkert H
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.
Journal of hypertension 1998;16(6):853-62.
-
1998: de Lannoy L M; Danser A H; Bouhuizen A M; Saxena P R; Schalekamp M A
Localization and production of angiotensin II in the isolated perfused rat heart.
Hypertension 1998;31(5):1111-7.
-
1998: Danser A H; de Vries R; Schoemaker R G; Saxena P R
Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors.
Journal of hypertension 1998;16(2):239-44.
-
1997: van Kesteren C A; Danser A H; Derkx F H; Dekkers D H; Lamers J M; Saxena P R; Schalekamp M A
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells.
Hypertension 1997;30(6):1389-96.
-
1997: Danser A H; van Kats J P; Verdouw P D; Schalekamp M A
Evidence for the existence of a functional cardiac renin-angiotensin system in humans.
Circulation 1997;96(10):3795-6.
-
1997: Knöll A; Schunkert H; Reichwald K; Danser A H; Bauer D; Platzer M; Stein G; Rosenthal A
Human renin binding protein: complete genomic sequence and association of an intronic T/C polymorphism with the prorenin level in males.
Human molecular genetics 1997;6(9):1527-34.
-
1997: Danser A H
Eighth European meeting on hypertension.
Expert opinion on investigational drugs 1997;6(8):1109-12.
-
1997: van Kesteren C A; van Heugten H A; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts.
Journal of molecular and cellular cardiology 1997;29(8):2147-57.
-
1997: Danser A H; van Kesteren C A; Bax W A; Tavenier M; Derkx F H; Saxena P R; Schalekamp M A
Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding.
Circulation 1997;96(1):220-6.
-
1997: de Lannoy L M; Danser A H; van Kats J P; Schoemaker R G; Saxena P R; Schalekamp M A
Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I.
Hypertension 1997;29(6):1240-51.
-
1997: Danser A H; MaassenVanDenBrink A; van Kesteren C A
69th scientific sessions of the American Heart Association.
Expert opinion on investigational drugs 1997;6(1):87-90.
-
1997: Schunkert H; Hense H W; Muscholl M; Luchner A; Kürzinger S; Danser A H; Riegger G A
Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.
Heart (British Cardiac Society) 1997;77(1):24-31.
-
1997: Schunkert H; Danser A H; Hense H W; Derkx F H; Kürzinger S; Riegger G A
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.
Circulation 1997;95(1):39-45.
-
1996: Danser A H; Schalekamp M A
Is there an internal cardiac renin-angiotensin system?
Heart (British Cardiac Society) 1996;76(3 Suppl 3):28-32.
-
1996: Danser A H
Local renin-angiotensin systems.
Molecular and cellular biochemistry 1996;157(1-2):211-6.
-
1996: van Kats J P; Sassen L M; Danser A H; Polak M P; Soei L K; Derkx F H; Schalekamp M A; Verdouw P D
Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
British journal of pharmacology 1996;117(5):891-901.
-
1995: Danser A H; Schalekamp M A; Bax W A; van den Brink A M; Saxena P R; Riegger G A; Schunkert H
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.
Circulation 1995;92(6):1387-8.
-
1995: Danser A H; Chowdury S; de Lannoy L M; van der Giessen W J; Saxena P R; Schalekamp M A
Conversion and degradation of [125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries.
Cardiovascular research 1995;29(6):789-95.
-
1994: Danser A H; van Kats J P; Admiraal P J; Derkx F H; Lamers J M; Verdouw P D; Saxena P R; Schalekamp M A
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.
Hypertension 1994;24(1):37-48.
-
1994: Danser A H; Derkx F H; Admiraal P J; Deinum J; de Jong P T; Schalekamp M A
Angiotensin levels in the eye.
Investigative ophthalmology & visual science 1994;35(3):1008-18.
-
1993: Danser A H; Admiraal P J; Derkx F H; de Bruyn J H; Schalekamp M A
Changes in plasma renin and angiotensin run in parallel after nephrectomy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S238-9.
-
1993: Danser A H; Admiraal P J; Derkx F H; Lamers J M; Verdouw P D; Saxena P R; Schalekamp M A
Cardiac renin is kidney-derived.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S224-5.
-
1993: Admiraal P J; Danser A H; Jong M S; Pieterman H; Derkx F H; Schalekamp M A
Regional angiotensin II production in essential hypertension and renal artery stenosis.
Hypertension 1993;21(2):173-84.
-
1992: Danser A H; Koning M M; Admiraal P J; Sassen L M; Derkx F H; Verdouw P D; Schalekamp M A
Production of angiotensins I and II at tissue sites in intact pigs.
The American journal of physiology 1992;263(2 Pt 2):H429-37.
-
1992: Danser A H; Koning M M; Admiraal P J; Derkx F H; Verdouw P D; Schalekamp M A
Metabolism of angiotensin I by different tissues in the intact animal.
The American journal of physiology 1992;263(2 Pt 2):H418-28.
-
1991: Danser A H; Sassen L M; Admiraal P J; Derkx F H; Verdouw P D; Schalekamp M A
Regional production of angiotensins I and II: contribution of vascular kidney-derived renin.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S234-5.
-
1991: Admiraal P J; Danser A H; Derkx F H; Schalekamp M A
Angiotensin II production in different vascular beds in hypertensive subjects.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S208-9.
-
1990: Admiraal P J; Derkx F H; Danser A H; Pieterman H; Schalekamp M A
Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis.
Hypertension 1990;16(5):555-63.
-
1990: Deinum J; Derkx F H; Danser A H; Schalekamp M A
Identification and quantification of renin and prorenin in the bovine eye.
Endocrinology 1990;126(3):1673-82.
-
1990: Admiraal P J; Derkx F H; Danser A H; Pieterman H; Schalekamp M A
Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.
Hypertension 1990;15(1):44-55.
-
1989: Admiraal P J; Derkx F H; Danser A H; Schalekamp M A
In vivo production of plasma angiotensin I: is plasma renin sufficient?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S222-3.
-
1989: Deinum J; Derkx F H; Danser A H; Schalekamp M A
Renin in the bovine eye.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S216-7.
-
1989: Danser A H; van den Dorpel M A; Deinum J; Derkx F H; Franken A A; Peperkamp E; de Jong P T; Schalekamp M A
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
The Journal of clinical endocrinology and metabolism 1989;68(1):160-7.
-
1988: Danser A H; van den Dorpel M A; Deinum J; Derkx F H; Peperkamp E; de Jong P T; Schalekamp M A
Prorenin in vitreous and subretinal fluid of the human eye.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1297-9.
Sign-in to see more
